MedPath
FDA Product

Tudorza Pressair

Product approved by U.S. Food and Drug Administration (US)

Basic Information

Tudorza Pressair

70515-002

Regulatory Information

70515-002

NDA202450

C73594

August 1, 2022

USA

These highlights do not include all the information needed to use TUDORZA PRESSAIR safely and effectively. See full prescribing information for TUDORZA PRESSAIR. TUDORZA PRESSAIR (aclidinium bromide inhalation powder)FOR ORAL INHALATION ONLYInitial U.S. Approval: 2012

HUMAN PRESCRIPTION DRUG LABEL

2

Company Information

118094829

Active Ingredients

lactose monohydrate

Code: EWQ57Q8I5X

Class Code: IACT

ACLIDINIUM BROMIDE

Quantity: 400 ug in 1 1

Code: UQW7UF9N91

Class Code: ACTIB

Active Moieties

ACLIDINIUM

Code: K17VY42F6C

© Copyright 2025. All Rights Reserved by MedPath